Name (Synonyms) | Correlation | |
---|---|---|
drug3023 | telehealth applications Wiki | 1.00 |
drug1747 | PT-Pal Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Our aim is to conduct a pilot single-blind randomized controlled trial to examine the preliminary efficacy of a 14 day app-based pulmonary and mobility focused rehabilitation program (intervention arm) versus a self-guided exercise program (active control arm) on pulmonary and functional outcomes in 100 patients tested for COVID-19 infection and isolated at home.
Description: The SGRQ is a valid instrument for measuring pulmonary function in patients with respiratory disease, with a total score and scores for symptom, physical activity, and impact domains (range 0 to 100; higher scores worse). The minimum clinically important difference is 4 points. The questionnaire has excellent reliability and validity compared to gold standard pulmonary function tests.
Measure: Change in pulmonary function (St George's Respiratory questionnaire: SGRQ) Time: baseline, at day 7 and at day 14Description: The AM-PAC was developed to examine basic mobility and daily activity functional activities important to adults. It is a validated measure of patient-reported functional limitation in 3 domains: basic mobility, daily activities, and applied cognition. It is endorsed by the National Quality Forum as a functional status quality metric.
Measure: Change in physical function (Activity Measure for Post-Acute Care: AM-PAC) Time: baseline, at day 7 and at day 14Description: Patient asked to take a deep breath while at rest and to hold it (Normal >25 s). Test monitored by video (Zoom, PT-Pal).
Measure: Change in pulmonary function (Sabrasez single breath count) Time: baseline, at day 7 and at day 14Description: Participants will be given a peak flow meter at recruitment, and taught how to use it by research staff over video.
Measure: Change in pulmonary function (Peak flow tests) Time: baseline, at day 7 and at day 14Description: This timed test assesses strength, balance and endurance. Test monitored by video (Zoom, PT-Pal).
Measure: Change in physical function (5 times site to stand test) Time: baseline, at day 7 and at day 14Description: Self-report or information from medical staff.
Measure: Health events (emergency room visits and hospitalizations) Time: baseline to day 14Description: Anxiety symptoms reported on the BAI. Higher scores indicate more anxiety.
Measure: Change in psychological measures (Beck Anxiety Inventory: BAI) Time: baseline, at day 7 and at day 14Description: Depressive symptoms reported on the CES-D. Higher score indicate more depressive symptoms.
Measure: Change in psychological measures (Center for Epidemiologic Studies Depression Scale: CES-D) Time: baseline, at day 7 and at day 14Description: Number of sessions completed using app in the intervention arm. Controls periodically interviewed.
Measure: Feasibility (Adherence) Time: baseline to day 14Description: Survey of satisfaction with exercise programs.
Measure: Feasibility (Acceptability) Time: baseline to day 14